Empowered Funds LLC Makes New $12.05 Million Investment in Humana Inc. $HUM

Empowered Funds LLC acquired a new stake in Humana Inc. (NYSE:HUM) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 30,339 shares of the insurance provider’s stock, valued at approximately $12,051,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Montag A & Associates Inc. increased its holdings in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the period. Johnson Financial Group Inc. purchased a new position in shares of Humana in the 2nd quarter valued at about $26,000. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana in the 4th quarter valued at about $27,000. Trust Co. of Vermont acquired a new position in shares of Humana during the second quarter worth about $28,000. Finally, Reflection Asset Management acquired a new position in shares of Humana during the fourth quarter worth about $29,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on HUM. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a report on Thursday, July 30th. William Blair initiated coverage on shares of Humana in a report on Wednesday, May 20th. They set an “outperform” rating for the company. Deutsche Bank Aktiengesellschaft initiated coverage on shares of Humana in a research report on Thursday, July 30th. They issued a “hold” rating on the stock. JPMorgan Chase & Co. raised their price objective on shares of Humana from $316.00 to $393.00 and gave the company a “neutral” rating in a report on Monday, August 10th. Finally, Raymond James Financial cut shares of Humana from an “outperform” rating to a “market perform” rating in a research report on Thursday, July 30th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and an average target price of $403.91.

Humana Stock Performance

Shares of HUM opened at $386.92 on Friday. The stock has a 50 day moving average price of $385.60 and a 200 day moving average price of $288.47. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $46.46 billion, a price-to-earnings ratio of 36.61, a price-to-earnings-growth ratio of 2.20 and a beta of 0.72. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion for the quarter, compared to analysts’ expectations of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The firm’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same quarter last year, the company earned $6.27 earnings per share. Research analysts predict that Humana Inc. will post 9.12 EPS for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.